Dr. Jerry Kaplan, M.D
NPI: 1811976657
Total Payments
$614.17
2024 Payments
$180.36
Companies
14
Transactions
24
Medicare Patients
878
Medicare Billing
$144,692
Payment Breakdown by Category
Food & Beverage$614.17 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $614.17 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $202.01 | 9 | $0 (2024) |
| TG Therapeutics, Inc. | $106.63 | 1 | $0 (2024) |
| Tris Pharma Inc | $43.70 | 2 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $34.16 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $33.90 | 2 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $31.49 | 1 | $0 (2022) |
| Grifols USA, LLC | $25.84 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $22.39 | 1 | $0 (2022) |
| Blueprint Medicines Corporation | $22.05 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $20.58 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180.36 | 4 | TG Therapeutics, Inc. ($106.63) |
| 2023 | $234.58 | 11 | ABBVIE INC. ($148.52) |
| 2022 | $184.18 | 8 | Dendreon Pharmaceuticals LLC ($34.16) |
| 2019 | $15.05 | 1 | ALK-Abello, Inc ($15.05) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $106.63 | General |
| Category: Immunology | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/26/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2023 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Immunology and Neurology | ||||||
| 06/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: EPILEPSY | ||||||
| 03/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: VIROLOGY | ||||||
| 02/17/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ADHD | ||||||
| 01/28/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ADHD | ||||||
| 01/26/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Rare Disease | ||||||
| 09/02/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Oncology | ||||||
| 08/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Oncology | ||||||
| 07/02/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Rare Disease | ||||||
| 04/15/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: Oncology | ||||||
| 03/25/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 01/28/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/29/2019 | ALK-Abello, Inc | Odactra (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Allergy and Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 321 | 446 | $312,515 | $48,425 |
| 2022 | 5 | 269 | 376 | $278,852 | $45,858 |
| 2021 | 5 | 233 | 333 | $245,896 | $41,692 |
| 2020 | 3 | 55 | 75 | $53,534 | $8,718 |
Total Patients
878
Total Services
1,230
Medicare Billing
$144,692
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 105 | 176 | $93,984 | $15,526 | 16.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 78 | 83 | $93,209 | $13,660 | 14.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 49 | 52 | $70,512 | $10,405 | 14.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 74 | 120 | $42,000 | $6,928 | 16.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 15 | 15 | $12,810 | $1,906 | 14.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 92 | 160 | $84,918 | $15,433 | 18.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 64 | 69 | $93,564 | $14,226 | 15.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 38 | 40 | $44,395 | $6,662 | 15.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 60 | 92 | $32,200 | $5,887 | 18.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 15 | 15 | $23,775 | $3,650 | 15.4% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 51 | 57 | $77,292 | $12,417 | 16.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 64 | 110 | $58,740 | $10,943 | 18.6% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 42 | 43 | $48,289 | $7,841 | 16.2% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 61 | 108 | $37,800 | $7,048 | 18.6% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 15 | 15 | $23,775 | $3,443 | 14.5% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 21 | 22 | $29,832 | $4,659 | 15.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 22 | 28 | $14,952 | $2,542 | 17.0% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2020 | 12 | 25 | $8,750 | $1,517 | 17.3% |
About Dr. Jerry Kaplan, M.D
Dr. Jerry Kaplan, M.D is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Huntington Station, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811976657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Kaplan, M.D has received a total of $614.17 in payments from pharmaceutical and medical device companies, with $180.36 received in 2024. These payments were reported across 24 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($614.17).
As a Medicare-enrolled provider, Kaplan has provided services to 878 Medicare beneficiaries, totaling 1,230 services with total Medicare billing of $144,692. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Location Huntington Station, NY
- Active Since 01/11/2006
- Last Updated 04/28/2021
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1811976657
Products in Payments
- QULIPTA (Drug) $111.60
- BRIUMVI (Drug) $106.63
- UBRELVY (Drug) $74.09
- Dyanavel XR (Drug) $43.70
- PROVENGE (Drug) $34.16
- ULTOMIRIS (Biological) $33.90
- XPOVIO (Drug) $31.49
- Gamunex-C (Biological) $25.84
- DARZALEX (Biological) $22.39
- AYVAKIT (Drug) $22.05
- KEYTRUDA (Biological) $20.58
- INJECTAFER (Drug) $20.24
- Nubeqa (Drug) $19.61
- VALTOCO (Drug) $16.52
- MAVYRET (Drug) $16.32
- Odactra (Drug) $15.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.